Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited (2633.HK) Stock Competitors & Peer Comparison
See (2633.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2633.HK | HK$1.67 | +0.00% | 3.3B | 10.93 | HK$0.15 | +3.96% |
| 3692.HK | HK$35.02 | -0.93% | 207.5B | 43.62 | HK$0.80 | +0.39% |
| 2196.HK | HK$18.59 | -2.97% | 75.3B | 15.70 | HK$1.20 | +1.86% |
| 0874.HK | HK$17.75 | -3.11% | 44.5B | 9.93 | HK$1.82 | +4.90% |
| 1513.HK | HK$37.62 | +0.32% | 38.9B | 14.88 | HK$2.52 | +3.20% |
| 3320.HK | HK$5.30 | -3.46% | 33.6B | 9.22 | HK$0.58 | +2.74% |
| 0867.HK | HK$12.99 | -5.18% | 32.2B | 18.27 | HK$0.73 | +2.24% |
| 0512.HK | HK$8.31 | -4.37% | 29.4B | 11.83 | HK$0.71 | +3.10% |
| 3933.HK | HK$14.70 | -0.54% | 28.7B | 9.10 | HK$1.60 | +3.32% |
| 0013.HK | HK$27.30 | -3.19% | 23.8B | -70.00 | -HK$0.39 | N/A |
Stock Comparison
2633.HK vs 3692.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 3692.HK has a market cap of 207.5B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 3692.HK trades at HK$35.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 3692.HK's P/E ratio is 43.62. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 3692.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 3692.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 3692.HK's competition here
2633.HK vs 2196.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2196.HK has a market cap of 75.3B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2196.HK trades at HK$18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2196.HK's P/E ratio is 15.70. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2196.HK's ROE of +0.06%. Regarding short-term risk, 2633.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 2196.HK's competition here
2633.HK vs 0874.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0874.HK has a market cap of 44.5B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0874.HK trades at HK$17.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0874.HK's P/E ratio is 9.93. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0874.HK's ROE of +0.07%. Regarding short-term risk, 2633.HK is less volatile compared to 0874.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0874.HK's competition here
2633.HK vs 1513.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1513.HK has a market cap of 38.9B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1513.HK trades at HK$37.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1513.HK's P/E ratio is 14.88. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1513.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 1513.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1513.HK's competition here
2633.HK vs 3320.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 3320.HK has a market cap of 33.6B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 3320.HK trades at HK$5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 3320.HK's P/E ratio is 9.22. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 3320.HK's ROE of +0.07%. Regarding short-term risk, 2633.HK is less volatile compared to 3320.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 3320.HK's competition here
2633.HK vs 0867.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0867.HK has a market cap of 32.2B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0867.HK trades at HK$12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0867.HK's P/E ratio is 18.27. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 2633.HK is less volatile compared to 0867.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0867.HK's competition here
2633.HK vs 0512.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0512.HK has a market cap of 29.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0512.HK trades at HK$8.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0512.HK's P/E ratio is 11.83. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0512.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 0512.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0512.HK's competition here
2633.HK vs 3933.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 3933.HK has a market cap of 28.7B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 3933.HK trades at HK$14.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 3933.HK's P/E ratio is 9.10. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 3933.HK's ROE of +0.19%. Regarding short-term risk, 2633.HK is less volatile compared to 3933.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 3933.HK's competition here
2633.HK vs 0013.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0013.HK has a market cap of 23.8B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0013.HK trades at HK$27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0013.HK's P/E ratio is -70.00. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0013.HK's ROE of +0.03%. Regarding short-term risk, 2633.HK is less volatile compared to 0013.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0013.HK's competition here
2633.HK vs 9989.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 9989.HK has a market cap of 19.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 9989.HK trades at HK$6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 9989.HK's P/E ratio is 12.96. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 9989.HK's ROE of +0.05%. Regarding short-term risk, 2633.HK is less volatile compared to 9989.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 9989.HK's competition here
2633.HK vs 1558.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1558.HK has a market cap of 14B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1558.HK trades at HK$15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1558.HK's P/E ratio is 26.47. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 2633.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1558.HK's competition here
2633.HK vs 6185.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 6185.HK has a market cap of 13.5B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 6185.HK trades at HK$44.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 6185.HK's P/E ratio is -26.04. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 6185.HK's ROE of -0.07%. Regarding short-term risk, 2633.HK is less volatile compared to 6185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 6185.HK's competition here
2633.HK vs 0460.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0460.HK has a market cap of 12B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0460.HK trades at HK$1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0460.HK's P/E ratio is -43.33. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0460.HK's ROE of -0.05%. Regarding short-term risk, 2633.HK is less volatile compared to 0460.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0460.HK's competition here
2633.HK vs 6600.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 6600.HK has a market cap of 11.8B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 6600.HK trades at HK$18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 6600.HK's P/E ratio is 10.12. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 6600.HK's ROE of +0.36%. Regarding short-term risk, 2633.HK is more volatile compared to 6600.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 6600.HK's competition here
2633.HK vs 1681.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1681.HK has a market cap of 11.5B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1681.HK trades at HK$13.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1681.HK's P/E ratio is 11.33. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1681.HK's ROE of +0.23%. Regarding short-term risk, 2633.HK is less volatile compared to 1681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1681.HK's competition here
2633.HK vs 0570.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0570.HK has a market cap of 11.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0570.HK trades at HK$2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0570.HK's P/E ratio is 227.00. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0570.HK's ROE of +0.00%. Regarding short-term risk, 2633.HK is more volatile compared to 0570.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 0570.HK's competition here
2633.HK vs 0719.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0719.HK has a market cap of 10.9B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0719.HK trades at HK$8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0719.HK's P/E ratio is 11.91. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0719.HK's ROE of +0.09%. Regarding short-term risk, 2633.HK is less volatile compared to 0719.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0719.HK's competition here
2633.HK vs 2005.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2005.HK has a market cap of 9.1B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2005.HK trades at HK$3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2005.HK's P/E ratio is 8.56. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2005.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 2005.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 2005.HK's competition here
2633.HK vs 2877.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2877.HK has a market cap of 6.1B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2877.HK trades at HK$8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2877.HK's P/E ratio is 6.73. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2877.HK's ROE of +0.11%. Regarding short-term risk, 2633.HK is more volatile compared to 2877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 2877.HK's competition here
2633.HK vs 6896.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 6896.HK has a market cap of 3.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 6896.HK trades at HK$4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 6896.HK's P/E ratio is 9.81. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 6896.HK's ROE of +0.23%. Regarding short-term risk, 2633.HK is less volatile compared to 6896.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 6896.HK's competition here
2633.HK vs 2552.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2552.HK has a market cap of 3.2B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2552.HK trades at HK$3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2552.HK's P/E ratio is -11.89. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2552.HK's ROE of +2.97%. Regarding short-term risk, 2633.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 2552.HK's competition here
2633.HK vs 1061.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1061.HK has a market cap of 2.9B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1061.HK trades at HK$5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1061.HK's P/E ratio is 9.64. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1061.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1061.HK's competition here
2633.HK vs 2161.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2161.HK has a market cap of 2.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2161.HK trades at HK$2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2161.HK's P/E ratio is 12.46. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2161.HK's ROE of +0.17%. Regarding short-term risk, 2633.HK is more volatile compared to 2161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 2161.HK's competition here
2633.HK vs 2348.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 2348.HK has a market cap of 2B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 2348.HK trades at HK$1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 2348.HK's P/E ratio is 3.27. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 2348.HK's ROE of +0.17%. Regarding short-term risk, 2633.HK is less volatile compared to 2348.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 2348.HK's competition here
2633.HK vs 1349.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1349.HK has a market cap of 1.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1349.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1349.HK's P/E ratio is 104.25. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1349.HK's ROE of +0.02%. Regarding short-term risk, 2633.HK is less volatile compared to 1349.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1349.HK's competition here
2633.HK vs 3839.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 3839.HK has a market cap of 1.4B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 3839.HK trades at HK$6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 3839.HK's P/E ratio is 16.20. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 3839.HK's ROE of +0.05%. Regarding short-term risk, 2633.HK is less volatile compared to 3839.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 3839.HK's competition here
2633.HK vs 8049.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 8049.HK has a market cap of 1.2B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 8049.HK trades at HK$2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 8049.HK's P/E ratio is 6.00. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 8049.HK's ROE of +0.08%. Regarding short-term risk, 2633.HK is more volatile compared to 8049.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 8049.HK's competition here
2633.HK vs 0950.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0950.HK has a market cap of 1.2B. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0950.HK trades at HK$1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0950.HK's P/E ratio is 12.44. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0950.HK's ROE of +0.06%. Regarding short-term risk, 2633.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0950.HK's competition here
2633.HK vs 0239.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0239.HK has a market cap of 766.6M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0239.HK trades at HK$2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0239.HK's P/E ratio is 9.84. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0239.HK's ROE of +0.11%. Regarding short-term risk, 2633.HK is more volatile compared to 0239.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 0239.HK's competition here
2633.HK vs 0503.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 2633.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0503.HK's competition here
2633.HK vs 3737.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 3737.HK has a market cap of 708.7M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 3737.HK trades at HK$0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 3737.HK's P/E ratio is 7.00. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 3737.HK's ROE of +0.09%. Regarding short-term risk, 2633.HK is less volatile compared to 3737.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 3737.HK's competition here
2633.HK vs 1011.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1011.HK has a market cap of 478.7M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1011.HK trades at HK$0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1011.HK's P/E ratio is -3.23. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1011.HK's ROE of +0.14%. Regarding short-term risk, 2633.HK is less volatile compared to 1011.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1011.HK's competition here
2633.HK vs 0897.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0897.HK has a market cap of 365.7M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0897.HK trades at HK$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0897.HK's P/E ratio is 32.50. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0897.HK's ROE of +0.00%. Regarding short-term risk, 2633.HK is less volatile compared to 0897.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0897.HK's competition here
2633.HK vs 0455.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0455.HK has a market cap of 356.9M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0455.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0455.HK's P/E ratio is -5.53. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 0455.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0455.HK's competition here
2633.HK vs 0858.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0858.HK has a market cap of 329.8M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0858.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0858.HK's P/E ratio is 1.97. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0858.HK's ROE of +0.15%. Regarding short-term risk, 2633.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 0858.HK's competition here
2633.HK vs 8329.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 8329.HK has a market cap of 275.2M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 8329.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 8329.HK's P/E ratio is 8.20. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 8329.HK's ROE of +0.03%. Regarding short-term risk, 2633.HK is less volatile compared to 8329.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 8329.HK's competition here
2633.HK vs 1652.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1652.HK has a market cap of 236.6M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1652.HK trades at HK$0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1652.HK's P/E ratio is -1.14. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1652.HK's ROE of -0.42%. Regarding short-term risk, 2633.HK is more volatile compared to 1652.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 1652.HK's competition here
2633.HK vs 8622.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 8622.HK has a market cap of 192.7M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 8622.HK trades at HK$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 8622.HK's P/E ratio is -38.50. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 8622.HK's ROE of -0.08%. Regarding short-term risk, 2633.HK is less volatile compared to 8622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 8622.HK's competition here
2633.HK vs 1498.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1498.HK has a market cap of 185.7M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1498.HK trades at HK$0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1498.HK's P/E ratio is -5.22. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1498.HK's ROE of -0.29%. Regarding short-term risk, 2633.HK is more volatile compared to 1498.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 1498.HK's competition here
2633.HK vs 1312.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 1312.HK has a market cap of 178.5M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 1312.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 1312.HK's P/E ratio is -3.20. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 1312.HK's ROE of -0.07%. Regarding short-term risk, 2633.HK is less volatile compared to 1312.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2633.HK.Check 1312.HK's competition here
2633.HK vs 0911.HK Comparison August 2025
2633.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2633.HK stands at 3.3B. In comparison, 0911.HK has a market cap of 41.5M. Regarding current trading prices, 2633.HK is priced at HK$1.67, while 0911.HK trades at HK$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2633.HK currently has a P/E ratio of 10.93, whereas 0911.HK's P/E ratio is 24.50. In terms of profitability, 2633.HK's ROE is +0.12%, compared to 0911.HK's ROE of +0.00%. Regarding short-term risk, 2633.HK is more volatile compared to 0911.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2633.HK.Check 0911.HK's competition here